APOE and gastric cancer: Intriguingly, when examining the association between APOE ε2 and gastric cancer subtype, an increased risk of gastric cancer was noted in ε2 carriers for both intestinal gastric cancer (P = 0.017) and diffuse gastric cancer (P = 0.0006) (Table 4).